We postulated that the presence of COX-2 and iNOS in MS plaques could also contribute to the increases in local concentrations of glutamate which could lead to axonal damage and cell death of oligodendrocytes and neurons [20]. The gene discussed is PTGS2; the disease is myeloid sarcoma.